Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-09 Sale | 2024-10-10 5:00 pm | Entero Therapeutics Inc. | ENTO | Romano Sarah Chief Financial Officer | 476 | $0.446 | $212 | 18,014 (Direct) | View |
| 2024-07-02 Sale | 2024-07-03 2:34 pm | Entero Therapeutics Inc. | ENTO | Romano Sarah Chief Financial Officer | 621 | $1.07 | $664 | 18,490 (Direct) | View |
| 2024-04-01 Sale | 2024-04-03 5:13 pm | First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer | 75 | $4.2294 | $317 | 19,111 (Direct) | View |
| 2024-03-15 Sale | 2024-03-19 4:10 pm | First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer | 1,120 | $4.96 | $5,555 | 19,186 (Direct) | View |
| 2024-01-12 Sale | 2024-01-17 4:02 pm | First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer | 98 | $4.2 | $412 | 20,306 (Direct) | View |
| 2023-10-04 Sale | 2023-10-06 4:05 pm | First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer | 1,676 | $0.29 | $486 | 15,800 (Direct) | View |
| 2023-07-03 Sale | 2023-07-05 4:28 pm | First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer | 1,977 | $1.54 | $3,045 | 17,476 (Direct) | View |
| 2023-04-03 Sale | 2023-04-05 4:17 pm | First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer | 1,975 | $2.5 | $4,938 | 19,453 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-29 Option Award | 2024-01-03 7:54 pm | N/A N/A | First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer | 19,614 | $0 | 20,404 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 09:01 am | N/A N/A | First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:02 pm | N/A 2032-03-01 | First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-02-10 Tax Withholding | 2022-02-11 4:31 pm | N/A N/A | KIORA PHARMACEUTICALS INC | KPRX | Romano Sarah Chief Financial Officer | 108 | $0.69 | 22,746 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 7:06 pm | N/A 2032-02-01 | KIORA PHARMACEUTICALS INC | KPRX | Romano Sarah Chief Financial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-01-05 Tax Withholding | 2022-01-06 5:10 pm | N/A N/A | KIORA PHARMACEUTICALS INC | KPRX | Romano Sarah Chief Financial Officer | 114 | $1.08 | 22,854 (Direct) | View |
| 2021-12-07 Tax Withholding | 2021-12-08 4:15 pm | N/A N/A | KIORA PHARMACEUTICALS INC | KPRX | Romano Sarah Chief Financial Officer | 91 | $1.3 | 22,968 (Direct) | View |
| 2021-11-02 Tax Withholding | 2021-11-03 4:15 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 83 | $1.98 | 23,059 (Direct) | View |
| 2021-10-04 Tax Withholding | 2021-10-05 6:40 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 83 | $2.01 | 23,142 (Direct) | View |
| 2021-09-02 Tax Withholding | 2021-09-03 4:16 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 84 | $1.81 | 23,225 (Direct) | View |
| 2021-08-03 Tax Withholding | 2021-08-04 5:45 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 87 | $2.4 | 23,309 (Direct) | View |
| 2021-07-02 Tax Withholding | 2021-07-06 4:32 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 180 | $3.7 | 23,396 (Direct) | View |
| 2021-06-04 Tax Withholding | 2021-06-07 5:02 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 180 | $4.19 | 23,576 (Direct) | View |
| 2021-05-04 Tax Withholding | 2021-05-05 9:57 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 177 | $4.13 | 23,756 (Direct) | View |
| 2021-04-08 Tax Withholding | 2021-04-09 4:16 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 180 | $4.94 | 23,933 (Direct) | View |
| 2021-03-03 Tax Withholding | 2021-03-05 4:31 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 218 | $5.46 | 24,113 (Direct) | View |
| 2021-02-02 Tax Withholding | 2021-02-03 9:53 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 1,282 | $6.34 | 54,331 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-03 9:53 pm | N/A 2031-02-01 | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 30,000 | $0 | 54,331 (Direct) | View |
| 2021-01-04 Tax Withholding | 2021-01-05 4:16 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 115 | $4.85 | 25,613 (Direct) | View |
| 2020-12-07 Tax Withholding | 2020-12-08 8:16 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 91 | $3.76 | 25,728 (Direct) | View |
| 2020-11-02 Tax Withholding | 2020-11-03 4:15 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 97 | $3.51 | 25,819 (Direct) | View |
| 2020-10-02 Tax Withholding | 2020-10-05 5:57 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 98 | $3.88 | 25,916 (Direct) | View |
| 2020-09-02 Tax Withholding | 2020-09-03 5:30 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 97 | $3.94 | 26,014 (Direct) | View |
| 2020-08-04 Tax Withholding | 2020-08-05 5:12 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 95 | $4.11 | 26,111 (Direct) | View |
| 2020-07-02 Tax Withholding | 2020-07-06 4:15 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 97 | $4.82 | 26,206 (Direct) | View |
| 2020-06-03 Tax Withholding | 2020-06-04 4:17 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 94 | $5.11 | 26,303 (Direct) | View |
| 2020-05-05 Tax Withholding | 2020-05-06 4:31 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 93 | $5.1 | 26,397 (Direct) | View |
| 2020-04-02 Tax Withholding | 2020-04-03 5:54 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 122 | $4.97 | 26,490 (Direct) | View |
| 2020-03-09 Tax Withholding | 2020-03-10 7:12 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 130 | $5.01 | 26,612 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:32 pm | N/A 2030-02-14 | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 10,000 | $0 | 36,742 (Direct) | View |
| 2020-02-04 Tax Withholding | 2020-02-05 5:00 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 109 | $6 | 16,742 (Direct) | View |
| 2020-01-03 Tax Withholding | 2020-01-06 5:47 pm | N/A N/A | EYEGATE PHARMACEUTICALS INC | EYEG | Romano Sarah Chief Financial Officer | 119 | $9.52 | 16,851 (Direct) | View |